Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ADMA
#1300
ADMA Biologics, Inc.
15.5
7
+5.49%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+5.49%
Monthly Change
-5.98%
6 month change
-10.05%
Cambio anual
+1.43%
Cierres anteriores
14.7
6
Open
15.5
7
Bid
Ask
Low
15.5
7
High
15.5
7
Volumen
204
Markets
Acciones
Atención Sanitaria
ADMA
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
121.28 M
195.92 M
222.16 M
228.22 M
237.62 M
238.16 M
—
Valuation ratios
Enterprise value
180.57 M
225.16 M
773.22 M
987.05 M
3.97 B
4.26 B
16.6 B
Price to earnings ratio
—
-2.76
-11.73
-35
21.17
30.4
92.69
Price to sales ratio
—
2.43
4.97
3.95
9.79
8.76
36.07
Price to cash flow ratio
—
-1.75
-12.87
115.81
35.17
88.64
236.52
Price to book ratio
—
1.39
5.04
7.54
11.96
9.36
19.22
Enterprise value to EBITDA ratio
-1.47
-4.2
-23.46
33.77
27.08
21.34
96.18
Profitability ratios
Return on assets %
-0.36
-0.26
-0.19
0.09
0.4
0.24
0.26
Return on equity %
-0.86
-0.51
-0.43
0.21
0.57
0.31
0.35
Return on invested capital %
-237.14
-139.79
-72.03
35.93
81.62
151.01
146.87
Gross margin %
-45.17
1.45
22.89
34.44
51.48
57.39
228.49
Operating margin %
-153.75
-72.12
-25.55
8.38
32.59
37.53
148.57
EBITDA margin %
-291.35
-66.19
-21.39
11.32
34.4
39.09
154.86
Net margin %
-179.41
-88.52
-42.77
10.94
46.35
28.8
114.11
Liquidity ratios
Quick ratio
3.62
2.77
2.73
1.69
2.9
3.74
13.52
Current ratio
7.71
6.87
6.89
5.16
5.97
6.71
25.74
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.25
0.33
0.49
0.76
1.04
0.92
0.93
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.45
0.34
0.41
0.4
0.15
0.11
0.51
Long term debt to total equity ratio
1.05
0.67
0.94
0.97
0.21
0.15
0.69
Per share metrics
Operating cash flow per share
—
-0.81
-0.3
0.04
0.49
0.21
0.21
EBIT per share
—
-0.42
-0.2
0.1
0.57
0.78
0.78
EBITDA per share
—
-0.38
-0.17
0.13
0.6
0.81
0.81
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
0.37
0.44
0.23
0.42
0.36
1.26
Net current asset value per share
—
1.5
1.37
1.15
1.36
1.9
6.6
Tangible book value per share
—
0.97
0.75
0.59
1.42
1.93
6.77
Working capital per share
—
1.28
1.17
0.93
1.13
1.62
5.56
Book value per share
—
1.01
0.77
0.6
1.43
1.95
6.84
Noticias
Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
ADMA Biologics Inc superaron 0.03$ las previsiones de BPA en el cuarto trimestre del año
ADMA Biologics Inc supera por 0,03$ las previsiones de BPA en el cuarto trimestre del año
ADMA Biologics Inc earnings beat by $0.03, revenue fell short of estimates
Resultados de ADMA Biologics: ¿puede el impulso igualar metas elevadas?
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
Adam Grossman, presidente de Adma Biologics, vende acciones por 337.679 dólares
Presidente de Adma Biologics, Adam Grossman, vende acciones por $337,679
Adam Grossman, president of Adma Biologics, sells $337,679 in shares
Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer